High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia

In acute myeloid leukemia (AML), risk stratification based on cytogenetics and mutation profiling is essential but remains insufficient to select the optimal therapy. Accurate biomarkers are needed to improve prognostic assessment. We analyzed RNA sequencing and survival data of 430 AML patients and...

Descripción completa

Detalles Bibliográficos
Autores principales: Marquis, Miriam, Beaubois, Cyrielle, Lavallée, Vincent-Philippe, Abrahamowicz, Michal, Danieli, Coraline, Lemieux, Sébastien, Ahmad, Imran, Wei, Andrew, Ting, Stephen B., Fleming, Shaun, Schwarer, Anthony, Grimwade, David, Grey, William, Hills, Robert K., Vyas, Paresh, Russell, Nigel, Sauvageau, Guy, Hébert, Josée
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066481/
https://www.ncbi.nlm.nih.gov/pubmed/30061630
http://dx.doi.org/10.1038/s41408-018-0103-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066481/
https://www.ncbi.nlm.nih.gov/pubmed/30061630
http://dx.doi.org/10.1038/s41408-018-0103-6

Ejemplares similares